These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 9169961
1. Modification of 35% carbon dioxide hypersensitivity across one week of treatment with clomipramine and fluvoxamine: a double-blind, randomized, placebo-controlled study. Perna G, Bertani A, Gabriele A, Politi E, Bellodi L. J Clin Psychopharmacol; 1997 Jun; 17(3):173-8. PubMed ID: 9169961 [Abstract] [Full Text] [Related]
2. Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study. Bertani A, Perna G, Arancio C, Caldirola D, Bellodi L. J Clin Psychopharmacol; 1997 Apr; 17(2):97-101. PubMed ID: 10950471 [Abstract] [Full Text] [Related]
5. Fluvoxamine as effective as clomipramine against symptoms of severe depression: results from a multicentre, double-blind study. Zohar J, Keegstra H, Barrelet L. Hum Psychopharmacol; 2003 Mar; 18(2):113-9. PubMed ID: 12590404 [Abstract] [Full Text] [Related]
11. Fluvoxamine or placebo in the treatment of panic disorder and relationship to blood concentrations of fluvoxamine. Sandmann J, Lörch B, Bandelow B, Härtter S, Winter P, Hiemke C, Benkert O. Pharmacopsychiatry; 1998 Jul; 31(4):117-21. PubMed ID: 9754844 [Abstract] [Full Text] [Related]
12. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators. Lecrubier Y, Bakker A, Dunbar G, Judge R. Acta Psychiatr Scand; 1997 Feb; 95(2):145-52. PubMed ID: 9065680 [Abstract] [Full Text] [Related]
14. Double-blindness procedure did not mask giving of medication in panic disorder. Bakker A, Spinhoven P, van Balkom AJ, Matser D, van Dyck R. J Affect Disord; 1999 Jul; 54(1-2):189-92. PubMed ID: 10403163 [Abstract] [Full Text] [Related]